Icosavax, Inc.

NASDAQ:ICVX

15.31 (USD) • At close February 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2022202120202019
Operating Activities:
Net Income -91.758-66.971-18.854-5.297
Depreciation & Amortization 0.860.0820.0010
Deferred Income Tax 00.959-0.1870
Stock Based Compensation 21.69429.0310.2570.072
Change In Working Capital 8.074-1.9054.1580.656
Accounts Receivables 0000
Inventory 0000
Accounts Payables -1.1951.8391.1190.452
Other Working Capital 9.269-3.7443.0390.204
Other Non Cash Items -0.5450.2640.4170
Operating Cash Flow -61.675-38.54-14.208-4.569
Investing Activities:
Investments In Property Plant And Equipment -11.113-1.006-0.0110
Acquisitions Net 158.336000
Purchases Of Investments -221.086000
Sales Maturities Of Investments 62.75000
Other Investing Activites -158.336000
Investing Cash Flow -169.449-1.006-0.0110
Financing Activities:
Debt Repayment 00-6.4640
Common Stock Issued 0190.7380.17426.742
Common Stock Repurchased 0000
Dividends Paid 0000
Other Financing Activities 10.307114.03412.9280
Financing Cash Flow 10.307304.7726.63826.742
Other Information:
Effect Of Forex Changes On Cash 0000
Net Change In Cash -220.817265.226-7.58122.173
Cash At End Of Period 59.907280.72415.49823.079